Growth Associate
About the job
- Have 1–3 years of experience in B2B SaaS sales (SDR/BDR), management consulting, or an analytical role in healthcare or technology.
- Be fluent in Spanish and have professional working English.
- Have prospecting and lead-generation skills.
- Be comfortable with numbers, building simple models, and interpreting data.
- Be able to research and navigate complex organizations, including hospital systems and healthcare networks.
- Maintain CRM discipline.
- Be able to work independently in fast-paced, unstructured environments.
- Research, prioritize, and map target hospitals and health systems, including their decision-makers.
- Design and execute targeted outbound sequences across email, LinkedIn, WhatsApp, calls, and events.
- Conduct first-touch discovery conversations to assess prospect interest, fit, and urgency, then pass opportunities to the VP of Revenue or founders.
- Prepare briefing documents with account context, stakeholder maps, past interactions, and strategic angles; join key calls and ensure timely follow-up.
- Model return on investment for proofs of concept and proposals, including physician time saved, documentation quality impact, and institutional financial upside.
- Maintain Attio records for accounts, contacts, opportunities, stages, and next steps; build and maintain pipeline dashboards, forecasts, and win/loss reports.
- Document outreach templates, talk tracks, objection handling, and pilot structures; build the sales playbook in Notion.
- Identify and launch initiatives to drive new business development growth and operational excellence.
- Execute events, trade shows, and client activations end-to-end, managing vendors, logistics, timelines, and budgets.
- Experience selling to or working with hospitals, insurers, or large healthcare providers.
- Familiarity with Attio, HubSpot, or Salesforce.
About the company
Telepatia provides AI-assisted medical documentation for Latin America, acting as an AI clinical co-pilot that drafts patient notes in real time during encounters. It integrates with clinics, hospitals, and telemedicine platforms across Colombia, Brazil, Peru, Mexico, Chile, Argentina, and more, with a focus on security and institutional onboarding. The AI listens to the patient encounter and clinician input to generate draft clinical notes that fit existing workflows and sync with health record systems. Its goal is to reduce time spent on documentation, improve note accuracy, and let clinicians focus more on patient care.
Company Size
51-200
Company Stage
Series A
Total Funding
$34.6M
Headquarters
São Paulo, Brazil
Founded
2025
Get referred to Telepatia
See people who can refer or advise you
Simplify's Take
What believers are saying
- June 2026 Series A from Andreessen Horowitz gives Telepatia capital and credibility.
- Mater Dei adopted Telepatia in September 2026, validating large-scale enterprise hospital demand.
- Telepatia claims 14 million patients and 25+ institutions across five Latin American countries.
What critics are saying
- Clinical documentation AI faces liability if transcription errors reach EMRs; one bad outcome triggers churn.
- Hospitals can replace Telepatia with native EMR scribe features from Epic, MV, or Tasy.
- If Brazilian or Colombian privacy audits fail, institutional deployments freeze and expansion stops.
What makes Telepatia unique
- Telepatia writes clinical notes in real time while physicians are still with patients.
- It integrates with 50+ hospital systems, including Tasy, MV, iClinic, and Epic.
- Institutional workflows keep doctor review, audit trails, and specialty protocols inside one system.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Growth & Insights and Company News
6 month growth
19%1 year growth
19%2 year growth
38%Telepatia AI raises R$ 169 million; Trace Finance raises R$ 166 million: the week's highlights. Healthtech Telepatia develops artificial intelligence agents to support doctors in consultations. 19/06/2026 10:00 Updated 19/06/2026 10:00 The last few days have been busy with announcements of large investments. The highlights are the Series A rounds raised by startups Telepatia AI, of AI agents for doctors, and Trace Finance, of financial infrastructure. The investments total R$ 335 million. In this newsletter, we also talk about the launch of the new edition of the Global Startup Ecosystem Report (GSER), by the consulting firm Startup Genome. For the second consecutive year, São Paulo appears in 37th place in the ranking of the world's most mature ecosystems. It is the only city in Latin America in the Top 40. You also read about Antler's first fund in Brazil, focused on early stage, which has investment from five public development institutions: BNDES, Finep, Badesul, BRDE and Fomento Paraná.
Telepatia raises $33M Series A led by Andreessen Horowitz. Telepatia, a healthtech startup, raised a $33M Series A round led by Andreessen Horowitz (a16z). Shyam Sankar, Simón Borrero, and David Vélez also participated in the round. The investment follows Telepatia's seed round in October 2025 Telepatia is building a platform that combines AI-powered documentation, clinical decision support, and AI healthcare workers, including AI doctors, nurses, and auditors. Telepatia's AI clinical assistant transcribes consultations in real time, reviews medical records, identifies potential drug interactions, and generates recommendations based on medical literature and clinical guidelines. With the funds, Telepatia will expand across Latin America and also plans to enter other underserved healthcare markets, including India, Africa, and Southeast Asia. Founded in 2025 by CEO Nicolas Abad, Telepatia has supported more than 14 million patients through over 25 public and private healthcare institutions across Brazil, Colombia, Mexico, Chile, and Argentina.
Telepatia AI has raised $33 million in a Series A round led by Andreessen Horowitz, bringing its total funding to $42 million. The startup builds an AI clinical copilot and scribe tool for Latin American hospitals, where 43% of deaths are considered preventable. The platform provides real-time transcription of medical visits, automatically generates electronic health records and delivers evidence-based decision support. Telepatia claims its tools save physicians over two hours of administrative work daily and improve protocol adherence by more than 15%. Founded by Nicolás Abad, the company has processed over 5 million consultations across more than 20 healthcare institutions. Palantir's Shyam Sankar and Nubank's David Vélez sit on the board. The startup offers free services to private-practice physicians lacking institutional support.
Telepatia AI raises $33 million in Series A led by a16z. With the investment, the healthtech, present in 5 countries, intends to accelerate expansion across Latin America. 06/17/2026 6:23 PM Updated 06/17/2026 6:23 PM Telepatia AI, a healthtech that develops artificial intelligence agents to assist doctors during consultations, announced the raise of $33 million (R$ 169.3 million, at current exchange rate) in a Series A round led by Andreessen Horowitz and a16z, bringing its total funding to $42 million (R$ 215.4 million). The capital will be used to expand its presence in Latin America and bring its technology to more hospitals and healthcare systems in the region. Among the investors are Shyam Sankar, CTO of Palantir; Simón Borrero, founder of Rappi; and David Vélez, founder of Nubank. The startup's platform acts as a "copilot" for healthcare professionals, with consultation monitoring, visit transcriptions, structured medical records, and conduct suggestions based on evidence and institutional protocols.
Telepatia AI raises $9M seed round. * byKatie Tincello * October 20, 2025 * 1 minute read Brazilian healthtech Telepatia AI raised a $9M seed round led by A-Star. Canary, Abstract, Picus, SV Angel, Nido, and additional angel investors also participated in the round. Telepatia AI is an online healthcare platform that uses artificial intelligence to support medical professionals. Its core product is an AI Doctor that transcribes consultations, generates medical reports, and helps make clinical decisions. The tool integrates with existing hospitals and clinical systems to improve patient care. Telepatia AI's team includes Stanford graduates and medical professionals, led by founder and CEO Nicolas Abad. Telepatia AI will use the funding to enhance the AI platform and expand across Latin America. * tags: * A-Star * brazil * healthtech * seed * Telepatia. Katie joined LatamList during her year abroad in Latin America and quickly became passionate about the emerging startup ecosystem. She now has 5+ years experience as a Content Writer and Strategist for entrepreneurs and companies across the technology, climate, healthcare, government and finance sectors across the globe.